Italian Pharma Company Selects Emerson to Enable Digital Transformation
AUSTIN, Texas--(BUSINESS WIRE)--Sep 12, 2018--FIS – Fabbrica Italiana Sintetici , a leading active pharmaceutical ingredients manufacturer, has selected Emerson (NYSE: EMR) to digitize operations and work processes at three manufacturing sites in Italy. With the $20 million (€16.1 million) contracts, Emerson will provide automation technology to help create a fully electronic manufacturing environment for increased efficiencies, quality and regulatory compliance.
“It is vital that FIS develops the right relationship to help it expand operations in a measured and prudent manner,” said Franco Moro, general manager of FIS. “Working with Emerson provides FIS with a trusted partner as we digitize work processes and invest in automation to improve production and efficiency.”
As part of its growth strategy, FIS constructed a new $123 million (€100 million) unit at its Termoli site, doubling capacity to produce active pharmaceutical ingredients. Emerson will implement its Syncade™ manufacturing execution system at the Termoli site, as well as the Montecchio facility, providing automated workflows and paperless procedures and record-keeping. Paperless manufacturing improves production efficiency and offers widespread benefits in compliance, product quality, inventory and document control, which are critical in the highly regulated pharmaceutical industry.
The two leading companies have partnered before; Emerson provided its DeltaV™ distributed control system to monitor and control manufacturing at the Termoli site in 2017. As part of this latest agreement, Emerson will expand the automation system to incorporate additional measurement and control instrumentation. By standardizing on DeltaV across its Termoli, Montecchio and Lonigo sites, FIS aims to improve efficiency and ensure consistent operations.
“This project reinforces Emerson’s strong relationship with FIS, and, as a trusted advisor, we will continue to support its business objectives on a long-term basis,” said Mike Train, executive president of Emerson Automation Solutions. “Our expertise will help FIS further automate work processes and boost profitability across these three sites as part of a companywide digital transformation strategy.”
The contracts are part of a 10-year strategic framework agreement signed with Emerson for the supply of its DeltaV and Syncade systems, measurement instrumentation and control valves, as well as a 10-year service agreement that covers the control systems at all three sites plus the new MES systems at Termoli and Montecchio.
Emerson (NYSE: EMR), headquartered in St. Louis, Missouri (USA), is a global technology and engineering company providing innovative solutions for customers in industrial, commercial, and residential markets. Our Emerson Automation Solutions business helps process, hybrid, and discrete manufacturers maximize production, protect personnel and the environment while optimizing their energy and operating costs. Our Emerson Commercial & Residential Solutions business helps ensure human comfort and health, protect food quality and safety, advance energy efficiency, and create sustainable infrastructure. For more information visit Emerson.com.
Media:Inquiries: AutomationSolutionsPR@Emerson.com Emerson Automation Solutions Global Media Contacts
Additional resources:Join the Emerson Automation Solutions Community Connect with Emerson Automation Solutions via TwitterFacebookLinkedInGoogle+YouTube
View source version on businesswire.com:https://www.businesswire.com/news/home/20180912005136/en/
CONTACT: For Emerson
Denise Clarke, 512-587-5879
KEYWORD: UNITED STATES EUROPE NORTH AMERICA TEXAS ITALY
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL MANUFACTURING ENGINEERING OTHER MANUFACTURING
Copyright Business Wire 2018.
PUB: 09/12/2018 09:00 AM/DISC: 09/12/2018 09:00 AM